Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rachana S. Bhimanwar & Amit Mittal. (2022) TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present). Expert Opinion on Therapeutic Patents 32:2, pages 191-209.
Read now
Read now
Chin-Hsiao Tseng, Kuo-Yang Lee & Farn-Hsuan Tseng. (2015) An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers. Journal of Environmental Science and Health, Part C 33:1, pages 67-124.
Read now
Read now
Articles from other publishers (58)
Emiliano Rosatelli, Andrea Carotti, Bruno Cerra, Francesca De Franco, Daniela Passeri, Roberto Pellicciari & Antimo Gioiello. (2023) Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives. European Journal of Medicinal Chemistry 261, pages 115851.
Crossref
Crossref
Weijun Lun, Qihao Yan, Xinghua Guo, Minchuan Zhou, Yan Bai, Jincan He, Hua Cao, Qishi Che, Jiao Guo & Zhengquan Su. (2023) Mechanism of action of the bile acid receptor TGR5 in obesity. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Zeyuan Lin, Shanshan Li, Haiming Xiao, Zhanchi Xu, Chuting Li, Jingran Zeng, Shaogui Wang, Zhongqiu Liu & Heqing Huang. (2023) The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy. Cell Reports 42:8, pages 112851.
Crossref
Crossref
Ruolin Gao, Xiangjing Meng, Yili Xue, Min Mao, Yaru Liu, Xuewen Tian, Bo Sui, Xun Li & Pengyi Zhang. (2022) Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus. Frontiers in Pharmacology 13.
Crossref
Crossref
Cristiana Caliceti, Angela Punzo, Alessia Silla, Patrizia Simoni, Giulia Roda & Silvana Hrelia. (2022) New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer. Nutrients 14:14, pages 2964.
Crossref
Crossref
Bozica Kovacevic, Melissa Jones, Corina Ionescu, Daniel Walker, Susbin Wagle, Jacqueline Chester, Thomas Foster, Daniel Brown, Momir Mikov, Armin Mooranian & Hani Al-Salami. (2022) The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications. Biomaterials 283, pages 121459.
Crossref
Crossref
Armin Mooranian, Melissa Jones, Corina Mihaela Ionescu, Daniel Walker, Susbin Raj Wagle, Bozica Kovacevic, Jacqueline Chester, Thomas Foster, Edan Johnston, Momir Mikov & Hani Al-Salami. (2022) Pharmaceutical formulation and polymer chemistry for cell encapsulation applied to the creation of a lab-on-a-chip bio-microsystem. Therapeutic Delivery 13:1, pages 51-65.
Crossref
Crossref
Meng Nie, Ke Yao, Xinsheng Zhu, Na Chen, Nan Xiao, Yi Wang, Bo Peng, LiAng Yao, Peng Li, Peng Zhang & Zeping Hu. (2021) Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nature Communications 12:1.
Crossref
Crossref
Xiaoman Wu, Fan Xiong, Hong Fang, Jie Zhang & Mingxian Chang. (2021) Crosstalks between NOD1 and Histone H2A Contribute to Host Defense against Streptococcus agalactiae Infection in Zebrafish. Antibiotics 10:7, pages 861.
Crossref
Crossref
Ting-Wei Kao & Chin-Chou Huang. (2021) Recent Progress in Metabolic Syndrome Research and Therapeutics. International Journal of Molecular Sciences 22:13, pages 6862.
Crossref
Crossref
Lili Ding, Qiaoling Yang, Eryun Zhang, Yangmeng Wang, Siming Sun, Yingbo Yang, Tong Tian, Zhengcai Ju, Linshan Jiang, Xunjiang Wang, Zhengtao Wang, Wendong Huang & Li Yang. (2021) Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice. Acta Pharmaceutica Sinica B 11:6, pages 1541-1554.
Crossref
Crossref
Michael RohrJihad AljabbanTrina Rudeski-RohrSpencer LessansSai Preethi NakkinaDexter HadleyXiang ZhuDeborah A. Altomare. (2021) Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer. Clinical and Translational Gastroenterology 12:1, pages e00295.
Crossref
Crossref
A. A. Shipovskaya, I. V. Kurbatova & O. P. Dudanova. (2020) Pleiotropic effects of ursodeoxycholic acid in patients with non-alcoholic steatohepatitis with impaired glycemic control. Experimental and Clinical Gastroenterology 183:11, pages 34-38.
Crossref
Crossref
А.Е. Абатуров & А.А. Никулина. (2020) Antibiotic Therapy as a Risk Factor of Obesity Development in Children. Педиатрия. Восточная Европа:2, pages 268-290.
Crossref
Crossref
Xiaoyin Wu, Ji-Yao Li, Allen Lee, Yuan-Xu Lu, Shi-Yi Zhou & Chung Owyang. (2020) Satiety induced by bile acids is mediated via vagal afferent pathways. JCI Insight 5:14.
Crossref
Crossref
Ai-Di Li, Xiao-Li Xie, Wei Qi, Wen-Bin Wang, Jun-Ji Ma, Dong-Qiang Zhao, Xiao-Yu Jiang, Lei Chen, Yun Bai & Hui-Qing Jiang. (2020) TGR5 promotes cholangiocarcinoma by interacting with mortalin. Experimental Cell Research 389:2, pages 111855.
Crossref
Crossref
Adel Bensalem, Babar Murtaza, Aziz Hichami, Amira Sayed Khan, Hayet Oulamara, Gregory Merlen, Mustapha Berrichi, Abdel-Nacer Agli, Thierry Tordjmann & Naim Akhtar Khan. (2020) Bile acid receptor TGR5 is critically involved in preference for dietary lipids and obesity. The Journal of Nutritional Biochemistry 76, pages 108298.
Crossref
Crossref
Li Deng, Xuxin Chen, Yi Zhong, Xing Wen, Ying Cai, Jiafu Li, Zhongcai Fan & Jian Feng. (2019) Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2019, pages 1-11.
Crossref
Crossref
Slavica Lazarević, Maja Đanić, Svetlana Goločorbin-Kon, Hani Al-Salami & Momir Mikov. (2019) Semisynthetic bile acids: a new therapeutic option for metabolic syndrome. Pharmacological Research 146, pages 104333.
Crossref
Crossref
F. Scott, S. Elahi, M. Adebibe, U. Parampalli, K. Mannur, A. Góralczyk & G. J. Sanger. (2019) Farnesoid X receptor ‐ a molecular predictor of weight loss after vertical sleeve gastrectomy?. Obesity Science & Practice 5:3, pages 273-280.
Crossref
Crossref
Ze Hua Zhao, Jonathan King‐Lam Lai, Liang Qiao & Jian Gao Fan. (2019) Role of gut microbial metabolites in nonalcoholic fatty liver disease. Journal of Digestive Diseases 20:4, pages 181-188.
Crossref
Crossref
Allison E. McQueen, Suneil K. Koliwad & Jen-Chywan Wang. (2018) Fighting obesity by targeting factors regulating beige adipocytes. Current Opinion in Clinical Nutrition & Metabolic Care 21:6, pages 437-443.
Crossref
Crossref
Raphael Chevre, Carlos Silvestre-Roig & Oliver Soehnlein. (2018) Nutritional Modulation of Innate Immunity: The Fat–Bile–Gut Connection. Trends in Endocrinology & Metabolism 29:10, pages 686-698.
Crossref
Crossref
Momir Mikov, Maja Đanić, Nebojša Pavlović, Bojan Stanimirov, Svetlana Goločorbin-Kon, Karmen Stankov & Hani Al-Salami. (2017) Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics. European Journal of Drug Metabolism and Pharmacokinetics 43:3, pages 269-280.
Crossref
Crossref
Jingyan Tian, Silvia Huang, Siming Sun, Lili Ding, Eryun Zhang, Yanjun Liu & Wendong Huang. (2017) Bile acid signaling and bariatric surgery. Liver Research 1:4, pages 208-213.
Crossref
Crossref
Louise Woodhams & Hani Al-Salami. (2017) The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus. Therapeutic Delivery 8:6, pages 401-409.
Crossref
Crossref
Chen-Guang Ji, Xiao-Li Xie, Jie Yin, Wei Qi, Lei Chen, Yun Bai, Na Wang, Dong-Qiang Zhao, Xiao-Yu Jiang & Hui-Qing Jiang. (2017) Bile acid receptor TGR5 overexpression is associated with decreased intestinal mucosal injury and epithelial cell proliferation in obstructive jaundice. Translational Research 182, pages 88-102.
Crossref
Crossref
Mohsen Mazidi, Pedro Paulo P. de Caravatto, John R. Speakman & Ricardo V. Cohen. (2017) Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids. Obesity Surgery 27:3, pages 826-836.
Crossref
Crossref
Simona De Marino, Adriana Carino, Dario Masullo, Claudia Finamore, Silvia Marchianò, Sabrina Cipriani, Francesco Saverio Di Leva, Bruno Catalanotti, Ettore Novellino, Vittorio Limongelli, Stefano Fiorucci & Angela Zampella. (2017) Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists. Scientific Reports 7:1.
Crossref
Crossref
J-Y Yang, Y-S Lee, Y. Kim, S-H Lee, S. Ryu, S. Fukuda, K. Hase, C-S Yang, H.S. Lim, M-S Kim, H-M Kim, S-H Ahn, B-E Kwon, H-J Ko & M-N Kweon. (2017) Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunology 10:1, pages 104-116.
Crossref
Crossref
Xiaojiaoyang Li, Runping Liu, Lan Luo, Linxi Yu, Xin Chen, Lixin Sun, Tao Wang, Phillip B. Hylemon, Huiping Zhou, Zhenzhou Jiang & Luyong Zhang. (2016) Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats. Archives of Toxicology 91:1, pages 481-494.
Crossref
Crossref
Yusra Azhar, Ashish Parmar, Colette N. Miller, Janaiya S. Samuels & Srujana Rayalam. (2016) Phytochemicals as novel agents for the induction of browning in white adipose tissue. Nutrition & Metabolism 13:1.
Crossref
Crossref
Fengxiao Xiong, Xuejuan Li, Zhiying Yang, Yu Wang, Wenyan Gong, Junying Huang, Cheng Chen, Peiqing Liu & Heqing Huang. (2016) TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-?1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling. Endocrine 54:3, pages 657-670.
Crossref
Crossref
Ahmed A. Gafar, Hossam M. Draz, Alexander A. Goldberg, Mohamed A. Bashandy, Sayed Bakry, Mahmoud A. Khalifa, Walid AbuShair, Vladimir I. Titorenko & J. Thomas Sanderson. (2016) Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells. PeerJ 4, pages e2445.
Crossref
Crossref
Frank J. Gonzalez, Changtao Jiang & Andrew D. Patterson. (2016) An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology 151:5, pages 845-859.
Crossref
Crossref
Min-Chan Chen, Yi-Ling Chen, Tzu-Wen Wang, Hui-Ping Hsu & Ming-Derg Lai. (2016) Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia. Oncology Reports 36:4, pages 1997-2008.
Crossref
Crossref
Shan-yao Ma, Meng-meng Ning, Qing-an Zou, Ying Feng, Yang-liang Ye, Jian-hua Shen & Ying Leng. (2016) OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition. Acta Pharmacologica Sinica 37:10, pages 1359-1369.
Crossref
Crossref
Chao Huang, Jili Wang, Wenfeng Hu, Chengniu Wang, Xu Lu, Lijuan Tong, Feng Wu & Wei Zhang. (2016) Identification of functional farnesoid X receptors in brain neurons. FEBS Letters 590:18, pages 3233-3242.
Crossref
Crossref
R. J. Hodge & D. J. Nunez. (2016)
Therapeutic potential of
T
akeda‐
G
‐protein‐receptor‐5 (
TGR5
) agonists.
H
ope or hype?
. Diabetes, Obesity and Metabolism 18:5, pages 439-443.
Crossref
Crossref
Tamara Zietek & Eva Rath. (2016) Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1. Frontiers in Immunology 7.
Crossref
Crossref
Valeria A. Rodríguez, María A. Rivoira, Adriana del V. Pérez, Ana M. Marchionatti & Nori G. Tolosa de Talamoni. (2016) Ursodeoxycholic and deoxycholic acids: Differential effects on intestinal Ca 2+ uptake, apoptosis and autophagy of rat intestine. Archives of Biochemistry and Biophysics 591, pages 28-34.
Crossref
Crossref
Armin Mooranian, Rebecca Negrulj & Hani Al-Salami. (2015) The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies. Drug Delivery and Translational Research 6:1, pages 17-23.
Crossref
Crossref
Lukasz Kaska, Tomasz Sledzinski, Agnieszka Chomiczewska, Agnieszka Dettlaff-Pokora & Julian Swierczynski. (2016) Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World Journal of Gastroenterology 22:39, pages 8698.
Crossref
Crossref
Laurence Poekes, Nicolas Lanthier & Isabelle A. Leclercq. (2015) Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome. Clinical Science 129:11, pages 933-949.
Crossref
Crossref
Alessia Perino & Kristina Schoonjans. (2015) TGR5 and Immunometabolism: Insights from Physiology and Pharmacology. Trends in Pharmacological Sciences 36:12, pages 847-857.
Crossref
Crossref
Claire Mazuy, Audrey Helleboid, Bart Staels & Philippe Lefebvre. (2014) Nuclear bile acid signaling through the farnesoid X receptor. Cellular and Molecular Life Sciences 72:9, pages 1631-1650.
Crossref
Crossref
Libor Vítek. (2015) Bile Acid Malabsorption in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:2, pages 476-483.
Crossref
Crossref
Bojan Stanimirov, Karmen Stankov & Momir Mikov. (2015) Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. Hepatobiliary & Pancreatic Diseases International 14:1, pages 18-33.
Crossref
Crossref
Tatyana V. Masyuk, Anatoliy I. Masyuk & Nicholas F. LaRusso. (2015) TGR5 in the Cholangiociliopathies. Digestive Diseases 33:3, pages 420-425.
Crossref
Crossref
Van Tran Thi Thuy, Cheol Won Lim, Jae Hyung Park, Cheol-Hee Ahn & Dukjoon Kim. (2015) Self-assembled nanoaggregates based on polyaspartamide graft copolymers for pH-controlled release of doxorubicin. Journal of Materials Chemistry B 3:15, pages 2978-2985.
Crossref
Crossref
Francesca Fava. 2015. Diet-Microbe Interactions in the Gut. Diet-Microbe Interactions in the Gut
127
137
.
Irina Voloshin, Michal Hahn-Obercyger, Sarit Anavi & Oren Tirosh. (2014) L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease. Lipids in Health and Disease 13:1.
Crossref
Crossref
Tiangang Li & John Y. L. Chiang. (2014) Bile Acid Signaling in Metabolic Disease and Drug Therapy. Pharmacological Reviews 66:4, pages 948-983.
Crossref
Crossref
Huijuan Ma & Mary Elizabeth Patti. (2014) Bile acids, obesity, and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 28:4, pages 573-583.
Crossref
Crossref
Sergio Lopez, Beatriz Bermudez, Sergio Montserrat-de la Paz, Sara Jaramillo, Lourdes M. Varela, Almudena Ortega-Gomez, Rocio Abia & Francisco J.G. Muriana. (2014) Membrane composition and dynamics: A target of bioactive virgin olive oil constituents. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838:6, pages 1638-1656.
Crossref
Crossref
Eng-Hong Pok. (2014) Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World Journal of Gastroenterology 20:39, pages 14315.
Crossref
Crossref
Sándor Sipka & Geza Bruckner. (2014) The Immunomodulatory Role of Bile Acids. International Archives of Allergy and Immunology 165:1, pages 1-8.
Crossref
Crossref
Abigale Lade, Luke A. Noon & Scott L. Friedman. (2014) Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. Current Opinion in Oncology 26:1, pages 100-107.
Crossref
Crossref